- Target
- NKG2C
- Reactivity
- Human
- Application
- FC,IF
- MW(Calculated)
- --
- MW(Observed)
- --
- Host Species
- Mouse
- Isotype
- Mouse IgG1/Kappa
- Conjugate/Modification
- Unmodified
- Modification site
- --
- Recommended Dilution Ratio
- IF 1:200-1:1000;FC:1 µg per million cells in 100 µl volume. For optimal results, the reagent should be titrated according to each specific application
- Form
- PBS, pH 7.4
- Source
- --
- Purification
- Protein A
- Purity
- --
- storageCondition
- Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.
- Concentration
- 0.5mg/ml
- Clonality
- Monoclonal
- Clone No.
- PTF0127
- Immunogen
- --
- Sequence
- --
- Specificity
- Endogenous
- Gene Name
- KLRC2 NKG2C
- Protein Name
- NKG2-C type II integral membrane protein (CD159 antigen-like family member C) (NK cell receptor C) (NKG2-C-activating NK receptor) (CD antigen CD159c)
- Other Name
- --
- Organism-1
- --
- Gene ID-1
- --
- SwissProt-1
- --
- Organism-2
- --
- Gene ID-2
- --
- SwissProt-2
- --
- Organism-3
- --
- Gene ID-3
- --
- SwissProt-3
- --
- Organism-4
- --
- gene ID-4
- --
- SwissProt-4
- --
- Cellular Localization
- Expressed in NK cell subsets, in particular in adaptive CD57-positive NK cells (at protein level) (PubMed:20952657, PubMed:21825173). Expressed in terminally differentiated cytotoxic gamma-delta T cells (at protein level) (PubMed:20952657). Expressed in alpha-beta T cells subsets (at protein level) (PubMed:20952657). KLRD1-KLRC1 and KLRD1-KLRC2 are differentially expressed within NK and T cell populations, with only minor subsets expressing both receptor complexes (at protein level) (PubMed:20952657).